Literature DB >> 5495179

Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism.

R Laverty, K M Taylor.   

Abstract

1. 6-Hydroxydopamine (200 mug injected intraventricularly) caused depletion of noradrenaline from all regions of rat brain within 2 h after injection but depletion of dopamine in the brain was observed only from 2 days after injection. Both catecholamines remained depleted for more than 32 days.2. Rats treated with intraventricular 6-hydroxydopamine were sedated and lethargic, with reduced spontaneous and exploratory activity, for periods of up to 8 days after injection. Conditioned avoidance responding was abolished or reduced for a similar period.3. Intraventricular 6-hydroxydopamine caused a prolonged reduction in the amount of labelled catecholamines in store 4 h following an intraventricular injection of (3)H-dopamine. During the first 6 h after 6-hydroxydopamine injection, there was a marked increase in neutral and acid metabolites from the labelled catecholamines.4. A comparison of the behavioural and biochemical effects of intraventricular 6-hydroxydopamine and reserpine suggests that both drugs affect catecholamine storage mechanisms but by different mechanisms. It was not possible from these experiments to correlate behavioural changes with either catecholamine storage or metabolism.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5495179      PMCID: PMC1702926          DOI: 10.1111/j.1476-5381.1970.tb10659.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Behavioral effects of some psychopharmacological agents.

Authors:  L COOK; E WEIDLEY
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

2.  An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine.

Authors:  J P Tranzer; H Thoenen
Journal:  Experientia       Date:  1968-02-15

3.  The New Zealand strain of rats with genetic hypertension.

Authors:  E L Phelan
Journal:  N Z Med J       Date:  1968-03

4.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

5.  Degeneration of adrenergic nerves produced by 6-hydroxydopamine.

Authors:  T Malmfors; C Sachs
Journal:  Eur J Pharmacol       Date:  1968-04       Impact factor: 4.432

6.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

Authors:  U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1968-12       Impact factor: 4.432

7.  Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain.

Authors:  N J Uretsky; L L Iversen
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

8.  The metabolism of tritiated dopamine in regions of the rat brain in vivo. II. The significance of the neutral metabolites of catecholamines.

Authors:  K M Taylor; R Laverty
Journal:  J Neurochem       Date:  1969-09       Impact factor: 5.372

9.  The metabolism of tritiated dopamine in regions of the rat brain in vivo. I. The separation of catecholamines and their metabolites.

Authors:  K M Taylor; R Laverty
Journal:  J Neurochem       Date:  1969-09       Impact factor: 5.372

Review 10.  Biogenic amines and emotion.

Authors:  J J Schildkraut; S S Kety
Journal:  Science       Date:  1967-04-07       Impact factor: 47.728

View more
  14 in total

1.  Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat.

Authors:  G Haeusler; M Gerold; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.

Authors:  J Vetulani; K Reichenberg; G Wiszniowska
Journal:  Psychopharmacologia       Date:  1974

3.  Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.

Authors:  B R Cooper; L D Grant; G R Breese
Journal:  Psychopharmacologia       Date:  1973-07-17

4.  Exploratory activity and conditioned avoidance acquistion after early postnatal 6-hydroxydopamine administration.

Authors:  C Nyakas; A M van Delft; J Kaplanski; P G Smelik
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

5.  Behaviour of rats and biogenic amine level in brain after 6-hydroxy-dopamine.

Authors:  Z S Herman; K Kmieciak-Kolada; R Brus
Journal:  Psychopharmacologia       Date:  1972

6.  Increased irritability: a permanent behavior change induced in the rat by intraventricular administration of 6-hydroxydopamine.

Authors:  K Nakamura; H Thoenen
Journal:  Psychopharmacologia       Date:  1972

7.  The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain.

Authors:  A A Boulton; A V Juorio; S R Philips; P H Wu
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

8.  Eating caused by 6-hydroxydopamine-induced release of noradrenaline in the diencephalon of the rat.

Authors:  K D Evetts; J T Fitzsimons; P E Setler
Journal:  J Physiol       Date:  1972-05       Impact factor: 5.182

9.  Pharmacological properties of centrally-administered agents which interfere with neurotransmitter function: a comparison with the central depressant effects of ouabain.

Authors:  N S Doggett; P S Spencer
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

10.  Contrasting roles of 5-hydroxytryptamine and noradrenaline in fever in rats.

Authors:  D M Ford; K P Klugman
Journal:  J Physiol       Date:  1980-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.